FDA Inspection
ALBA Bioscience LimitedALBA Bioscience Limited – FDA Inspection, Mar 17, 2023
Record Details
This FDA Inspection record concerns ALBA Bioscience Limited, with an inspection on March 17, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 0d817ba4-a512-41b1-86de-e7393ff30391
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200022
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 803.50(a)(2)Individual Report of Malfunction
- 21 CFR 820.120Lack of or inadequate procedures for labeling
- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
- 21 CFR 803.17(a)(1)Lack of System for Event Evaluations
- 21 CFR 803.17(a)(1)Lack of System for Event Evaluations
- 21 CFR 803.50(a)(2)Individual Report of Malfunction
- 21 CFR 820.120Lack of or inadequate procedures for labeling
- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ALBA Bioscience Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | Not classified | Office of Inspections and Investigations | |
| August 31, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for ALBA Bioscience Limited
- FDA Inspection 1258599 - 2025-02-21
- FDA Inspection 1069657 - 2018-08-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.